The paper by Thornton et al. [1] contains the following error. On page 8:
The authors also wish to thank the following individuals for their contributions: Sergio Forero-Swanhaeuser, MD, Trish McBride, MS, of GlaxoSmithKline and Annette Ferrell, formerly of GlaxoSmithKline, for clinical study oversight and management; Kay S. Tatsuoka for statistical design input and analysis, Douglas Wicks, MPH, CMPP, from GlaxoSmithKline, for management of manuscript development and Rosemary Perkins of Caudex Inc. for editorial assistance in preparation of the manuscript (funded by GlaxoSmithKline).
Should read:
The authors also wish to thank the following individuals for their contributions: Sergio Forero-Swanhaeuser, MD, Trish McBride, MS, of GlaxoSmithKline and Annette Ferrell, formerly of GlaxoSmithKline, for clinical study oversight and management; Kay S. Tatsuoka for statistical design input and analysis, Douglas Wicks, MPH, CMPP, from GlaxoSmithKline, for management of manuscript development; Kim Poinsett-Holmes, PharmD (Poinsett Publications, Inc.), and Rosemary Perkins of Caudex Inc. for editorial assistance in preparation of the manuscript (funded by GlaxoSmithKline).
The authors wish to apologize for this error.
Reference
- 1.Thornton S, Miller H, Valenzuela G, Snidow J, Stier B, Fossler MJ, Montague TH, Powell M, Beach KJ. Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study. Br J Clin Pharmacol. 2015 doi: 10.1111/bcp.12646. doi: 10.1111/bcp.12646. [DOI] [PMC free article] [PubMed] [Google Scholar]